All Stories

  1. Sex differences in hypertrophic cardiomyopathy: Time to tailor risk stratification and therapy?
  2. Congenital heart disease, pulmonary arterial hypertension and the UK’s Drivers and Vehicle Licensing Agency: controversial new guidance
  3. Modifiable risk factors in congenital heart disease: Education, transition, digital health and choice architecture
  4. Tricuspid regurgitation severity after atrial septal defect closure or pulmonic valve replacement
  5. The effects of parenteral prostacyclin therapy as add-on treatment to oral compounds in Eisenmenger syndrome
  6. Eisenmenger syndrome and other types of pulmonary arterial hypertension related to adult congenital heart disease
  7. EmPHasis-10 score for the assessment of quality of life in various types of pulmonary hypertension and its relation to outcome
  8. Strength training in congenital heart disease: A way to boost respiratory function?
  9. Management of Adults With Congenital Heart Disease and Pulmonary Arterial Hypertension in the UK: Survey of Current Practice, Unmet Needs and Expert Commentary
  10. Definition and Management of Segmental Pulmonary Hypertension
  11. Acute Effect of Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Simple Congenital Heart Defects
  12. Heart Failure, Exercise Intolerance, and Physical Training
  13. Infective endocarditis in patients with congenital heart disease: When, where and how
  14. A crown of thorns—right ventricular outflow tract obstruction caused by calcific pericardial ring
  15. Pulmonary Arterial Hypertension Complicating Congenital Heart Disease: Advances in Therapy
  16. The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension
  17. Response by Kempny et al to Letter Regarding Article, “Predictors of Death in Contemporary Adult Patients With Eisenmenger Syndrome: A Multicenter Study”
  18. Pacing in congenital heart disease – A four-decade experience in a single tertiary centre
  19. Infective endocarditis in adults with congenital heart disease remains a lethal disease
  20. The spectrum of pulmonary arterial hypertension in adults with congenital heart disease: management from a physician and nurse specialist perspective
  21. Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry
  22. Platelet count and mean platelet volume predict outcome in adults with Eisenmenger syndrome
  23. Outcome of cardiac surgery in patients with congenital heart disease in England between 1997 and 2015
  24. Declining incidence and prevalence of Eisenmenger syndrome in the developed world: a triumph of modern medicine
  25. Past and current cause-specific mortality in Eisenmenger syndrome
  26. Predictors of Death in Contemporary Adult Patients With Eisenmenger Syndrome
  27. Body mass index in adult congenital heart disease
  28. Eisenmenger syndrome: current perspectives
  29. OUP accepted manuscript
  30. Cardiac remodelling amongst adults with various aetiologies of pulmonary arterial hypertension including Eisenmenger syndrome—implications on survival and the role of right ventricular transverse strain
  31. Dyssynchrony and electromechanical delay are associated with focal fibrosis in the systemic right ventricle — Insights from echocardiography
  32. Patients with Down syndrome and congenital heart disease: survival is improving, but challenges remain: Table 1
  33. Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy
  34. Clinical course and potential complications of small ventricular septal defects in adulthood: Late development of left ventricular dysfunction justifies lifelong care
  35. On the question of adjustment for multiple testing
  36. Multimodality imaging in congenital heart disease-related pulmonary arterial hypertension
  37. Chronic Heart Failure in Congenital Heart Disease
  38. Transplantation and Mechanical Circulatory Support in Congenital Heart Disease
  39. Physiologic determinants of exercise capacity in patients with different types of right-sided regurgitant lesions: Ebstein's malformation with tricuspid regurgitation and repaired tetralogy of Fallot with pulmonary regurgitation
  40. Common long-term complications of adult congenital heart disease: avoid falling in a H.E.A.P.
  41. Unable to Access the Pulmonary Artery
  42. Determinants of outpatient clinic attendance amongst adults with congenital heart disease and outcome
  43. Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa
  44. Impaired Right, Left, or Biventricular Function and Resting Oxygen Saturation Are Associated With Mortality in Eisenmenger Syndrome
  45. Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients Under Follow-Up at a Large Tertiary Centre
  46. 2015 ESC Guidelines for the management of infective endocarditis
  47. Prognostic importance of depression in congenital heart disease
  48. Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension?
  49. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: Challenges and future directions
  50. Exclusion of a giant aneurysm post-Kawasaki disease with novel polyurethane covered stents
  51. Hypoalbuminaemia predicts outcome in adult patients with congenital heart disease
  52. Acceptance and psychological impact of implantable defibrillators amongst adults with congenital heart disease
  53. 0418: Survival advantage of Eisenmenger syndrome patients: the role of right ventricular transverse strain
  54. Physiological differences between various types of Eisenmenger syndrome and relation to outcome
  55. Right Heart and Pulmonary Vessels Structure and Function
  56. Antidepressant Use in Pregnancy and the Risk of Cardiac Defects
  57. Single-ventricle physiology in the UK: an ongoing challenge of growing numbers and of growing complexity of congenital heart disease
  58. Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experience
  59. CASE 10—2014Eisenmenger Syndrome: Close the Hole?
  60. Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia
  61. Long-term natural history and postoperative outcome of double-chambered right ventricle—Experience from two tertiary adult congenital heart centres and review of the literature
  62. Repair of tetralogy of Fallot—how much can we achieve with a single operation?
  63. C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value
  64. Prevalence and prognostic implication of restenosis or dilatation at the aortic coarctation repair site assessed by cardiovascular MRI in adult patients late after coarctation repair
  65. Choice and Competition Between Adult Congenital Heart Disease Centers
  66. Lung function and gas exchange in Eisenmenger syndrome and their impact on exercise capacity and survival
  67. Myocardial fibrosis in Eisenmenger syndrome: a descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival
  68. Eisenmenger syndrome in an adult patient with a large patent ductus arteriosus
  69. Pulmonary hypertension related to congenital heart disease: a call for action
  70. Nuclear Factor κ-B Is Activated in the Pulmonary Vessels of Patients with End-Stage Idiopathic Pulmonary Arterial Hypertension
  71. Histopathology of the great vessels in patients with pulmonary arterial hypertension in association with congenital heart disease: Large pulmonary arteries matter too
  72. Six-minute walk test distance and resting oxygen saturations but not functional class predict outcome in adult patients with Eisenmenger syndrome
  73. Meeting the challenge: The evolving global landscape of adult congenital heart disease
  74. Eisenmenger Syndrome and Other Types of Pulmonary Arterial Hypertension Related to Congenital Heart Disease
  75. Outcome in adult patients after arterial switch operation for transposition of the great arteries
  76. Prognostic value of C-reactive protein in patients with Eisenmenger syndrome
  77. Surgically treated subaortic stenosis: aspects beyond the recurrence
  78. Echocardiographic insights into pulmonary arterial hypertension: the "advantage" of congenital heart disease patients
  79. Qrs duration predicts life-threatening ventricular arrhythmia and death in adults with a systemic right ventricle
  80. Prognostic value of ECG parameters in patients with Eisenmenger syndrome
  81. Impact of socioeconomic status and gender on access to healthcare and outcome in adults with congenital heart disease
  82. Infective endocarditis in adults with congenital heart disease: still a potentially lethal disease
  83. Six minute walk test but not functional class predicts outcome in adult patients with Eisenmenger syndrome
  84. Disease targeting therapies in patients with Eisenmenger syndrome: Response to treatment and long-term efficiency
  85. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality
  86. Biomarkers in congenital heart disease: do natriuretic peptides hold the key?
  87. Cardiothoracic ratio from postero-anterior chest radiographs: A simple, reproducible and independent marker of disease severity and outcome in adults with congenital heart disease
  88. Relationship of Cardiac Output to Respiratory Pattern and Pressures in Patients With Fontan Circulation
  89. From Other Journals
  90. Detrimental impact of socioeconomic status on exercise capacity in adults with congenital heart disease
  91. Paracardiac mass on chest X-ray in a patient with Eisenmenger syndrome
  92. Peak oxygen uptake correlates with disease severity and predicts outcome in adult patients with Ebstein's anomaly of the tricuspid valve
  93. Adult Congenital Heart Disease
  94. Abnormal Lung Function in Adults With Congenital Heart Disease: Prevalence, Relation to Cardiac Anatomy, and Association With Survival
  95. Giant Saphenous Vein Graft Aneurysm Compressing Right Ventricular Outflow Tract and Main Pulmonary Artery
  96. Magnetic navigation in adults with atrial isomerism (heterotaxy syndrome) and supraventricular arrhythmias
  97. 270: Effects of advanced therapies on echocardiographic and Doppler measures, compared with clinical evaluation and BNP in patients with Eisenmenger syndrome
  98. Improved cardiac survival, freedom from mace and angina-related quality of life after successful percutaneous recanalization of coronary artery chronic total occlusions
  99. Echocardiographic Predictors of Outcome in Eisenmenger Syndrome
  100. Arterial switch repair to transposition of great arteries: So far so good
  101. Response to Letter Regarding Article, “Comprehensive Use of Cardiopulmonary Exercise Testing Identifies Adults With Congenital Heart Disease at Increased Mortality Risk in the Medium Term”
  102. B-type natriuretic peptide at the early stage of univentricular circulation reflects inadequate adaptation to volume overload
  103. Left Ventricular Longitudinal Function Predicts Life-Threatening Ventricular Arrhythmia and Death in Adults With Repaired Tetralogy of Fallot
  104. Systemic right ventricular longitudinal strain is reduced in adults with transposition of the great arteries, relates to subpulmonary ventricular function, and predicts adverse clinical outcome
  105. Atrial tachyarrhythmias late after Fontan operation are related to increase in mortality and hospitalization
  106. A bleeding conundrum
  107. B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy
  108. ECHOCARDIOGRAPHIC PREDICTORS OF OUTCOME IN EISENMENGER SYNDROME
  109. Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: Implications on optimisation of timing of treatment from the CARESS-in-AMI trial
  110. Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation
  111. Comprehensive Use of Cardiopulmonary Exercise Testing Identifies Adults With Congenital Heart Disease at Increased Mortality Risk in the Medium Term
  112. The relation between significant stenosis or dilatation at the repair site and outcome in a contemporary cohort of patients with repaired aortic coarctation as assessed using Cardiovascular Magnetic Resonance
  113. Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life--single centre experience and review of published data
  114. Chapter 9 Eisenmenger complex
  115. Total isovolumic time relates to exercise capacity in patients with transposition of the great arteries late after atrial switch procedures
  116. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome
  117. Cardiovascular changes after transcatheter endovascular stenting of adult aortic coarctation
  118. Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy
  119. GLOBAL SYSTEMIC VENTRICULAR LONGITUDINAL STRAIN IS REDUCED IN ADULTS WITH TRANSPOSITION OF THE GREAT ARTERIES AND A SYSTEMIC RIGHT VENTRICLE AND RELATES TO SUBPULMONARY VENTRICULAR FUNCTION AND ADVERSE CLINICAL OUTCOME
  120. Exercise intolerance in patients with congenitally corrected transposition of the great arteries relates to right ventricular filling pressures
  121. Heart Failure, Exercise Intolerance, and Physical Training
  122. Atrial septal defect closure is associated with a reduced prevalence of atrial tachyarrhythmia in the short to medium term: a systematic review and meta-analysis
  123. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients
  124. Ventrículo derecho y cardiopatías congénitas en el adulto
  125. Cerebrovascular accidents in adult patients with congenital heart disease
  126. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis
  127. Recurrence of cerebrovascular events in young adults with a secundum atrial septal defect
  128. Accuracy of OCT in Evaluating Neointimal Thickness After Stent Implantation
  129. Optimised rate-responsive pacing does not improve either right ventricular haemodynamics or exercise capacity in adults with a systemic right ventricle
  130. Quantitative analysis of intracoronary optical coherence tomography measurements of stent strut apposition and tissue coverage
  131. Diagnostic accuracy meta-analysis: A review of the basic principles of interpretation and application
  132. Non-invasive assessment of pulmonary blood flow using an inert gas rebreathing device in fibrotic lung disease
  133. EARLY PCI AFTER THROMBOLYSIS VERSUS STANDARD THERAPY IN STEMI PATIENTS: A CUMULATIVE META-ANALYSIS
  134. Usefulness of Natriuretic Peptide Levels to Predict Mortality in Adults With Congenital Heart Disease
  135. The Impact of Transcatheter Atrial Septal Defect Closure in the Older Population
  136. A modelling study of atrial septostomy for pulmonary arterial hypertension, and its effect on the state of tissue oxygenation and systemic blood flow
  137. Improved Survival Among Patients With Eisenmenger Syndrome Receiving Advanced Therapy for Pulmonary Arterial Hypertension
  138. Ebstein Anomaly and Sudden Cardiac Death
  139. Heart Failure in Adults with Congenital Heart Disease
  140. Exercise training in congenital heart disease: Should we follow the heart failure paradigm?
  141. Congenital Heart Disease
  142. Hyponatraemia: a strong predictor of mortality in adults with congenital heart disease
  143. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study
  144. Anemia in Adults With Congenital Heart Disease Relates to Adverse Outcome
  145. Structural Abnormalities of the Pulmonary Trunk in Tetralogy of Fallot and Potential Clinical Implications
  146. Burden of Coronary Artery Disease in Adults With Congenital Heart Disease and Its Relation to Congenital and Traditional Heart Risk Factors
  147. Impaired heart rate response to exercise in adult patients with a systemic right ventricle or univentricular circulation: Prevalence, relation to exercise, and potential therapeutic implications
  148. The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography
  149. Modelling in congenital heart disease. Art or science?
  150. Ventilatory Efficiency and Aerobic Capacity Predict Event-Free Survival in Adults With Atrial Repair for Complete Transposition of the Great Arteries
  151. Bosentan in mild pulmonary hypertension
  152. Near miss sudden cardiac death on a young patient with repaired atrioventricular septal defect
  153. Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications
  154. Letter by Barlis et al Regarding Article, “Two-Year Clinical Outcomes With Drug-Eluting Stents for Diabetic Patients With De Novo Coronary Lesions: Results From a Real-World Multicenter Registry
  155. Cardiovascular and ventilatory control during exercise in chronic heart failure: Role of muscle reflexes
  156. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents
  157. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?
  158. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy
  159. Trials and tribulations in adult congenital heart disease
  160. Prevalence, Predictors, and Prognostic Value of Renal Dysfunction in Adults With Congenital Heart Disease
  161. Haemodynamic significance of an anomalous right coronary with inter-arterial course assessed with intracoronary pressure measurements during dobutamine challenge
  162. Bronchial Artery Embolization for Pulmonary Arterial Hypertension and Recurrent Hemoptysis?
  163. Response to Letter Regarding Article, "Right Ventricular Mechanics and QRS Duration in Patients With Repaired Tetralogy of Fallot: Implications of Infundibular Disease"
  164. Optical coherence tomography to assess malapposition in overlapping drug-eluting stents
  165. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial
  166. An indeterminate occlusion duration predicts procedural failure in the recanalization of coronary chronic total occlusions
  167. Instantaneous effects of resynchronisation therapy on exercise performance in heart failure patients: the mechanistic role and predictive power of total isovolumic time
  168. Comparison of Bare-Metal and Sirolimus- or Paclitaxel-Eluting Stents for Aorto-Ostial Coronary Disease
  169. Immediate procedural and long-term clinical outcomes following drug-eluting stent implantation to ostial saphenous vein graft lesions
  170. Model of chronic adaptation: right ventricular function in Eisenmenger syndrome
  171. Right Ventricular Mechanics and QRS Duration in Patients With Repaired Tetralogy of Fallot
  172. Culotte versus T-stenting in bifurcation lesions: Immediate clinical and angiographic results and midterm clinical follow-up
  173. Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease
  174. The Effect of Drug-Eluting Stents on Collateral Coronary Flow
  175. Deep vein thrombosis in a patient with congenital heart disease and permanent transfemoral pacing
  176. Approach to intermediate lesions
  177. A new quantitative analysis system for the evaluation of coronary bifurcation lesions: Comparison with current conventional methods
  178. 400 Long axis dysfunction and tricuspid regurgitation relate to ventricular fibrosis in adults with systemic right ventricle and complete transposition of the great arteries
  179. Exercise Intolerance in Adults with Congenital Heart Disease
  180. Analytical Identification of Ideal Pulmonary-Systemic Flow Balance in Patients With Bidirectional Cavopulmonary Shunt and Univentricular Circulation
  181. Heart Rate Response During Exercise Predicts Survival in Adults With Congenital Heart Disease
  182. Abnormal Ventilatory Response to Exercise in Adults With Congenital Heart Disease Relates to Cyanosis and Predicts Survival
  183. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study
  184. Exercise Intolerance in Adult Congenital Heart Disease
  185. Chronotropic incompetence is prevalent in adult congenital heart disease patients, determines exercise capacity and identifies high risk patients
  186. Review finds combining angiotensin receptor blockers with ACE inhibitors in heart failure may only benefit people with contraindications to β blockersAbstracted from: Dimopoulos K, Salukhe TV, Coats AJ, et al. Meta-analyses of mortality and morbidity e...
  187. Review finds combining angiotensin receptor blockers with ACE inhibitors in heart failure may only benefit people with contraindications to β blockers
  188. Life-Years Gained From Defibrillator Implantation
  189. Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC
  190. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a β-blocker)
  191. Multiple coronary rupture after blunt chest trauma
  192. Activity–rest stimulation protocol improves cardiac assistance in dynamic cardiomyoplasty
  193. Fatal aortoesophageal fistula in two cases of tight vascular ring
  194. New Advances in Dynamic Cardiomyoplasty: Doppler Flow Wire Shows Improved Cardiac Assistance in Demand Protocol
  195. Endoluminal Repair of a Dardik Prosthesis Pseudoaneurysm Using the Wallgraft Endoprosthesis